Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Occludin antibody (AA 282-415)

The Mouse Monoclonal anti-Occludin antibody has been validated for WB and IHC (f). It is suitable to detect Occludin in samples from Human.
Catalog No. ABIN6938100

Quick Overview for Occludin antibody (AA 282-415) (ABIN6938100)

Target

See all Occludin (OCLN) Antibodies
Occludin (OCLN)

Reactivity

  • 126
  • 64
  • 44
  • 34
  • 18
  • 12
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
Human

Host

  • 96
  • 38
  • 3
  • 1
Mouse

Clonality

  • 90
  • 48
Monoclonal

Conjugate

  • 63
  • 11
  • 6
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
This Occludin antibody is un-conjugated

Application

  • 105
  • 47
  • 37
  • 32
  • 26
  • 26
  • 20
  • 20
  • 17
  • 15
  • 13
  • 6
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

OCLN-2181
  • Binding Specificity

    • 22
    • 16
    • 16
    • 11
    • 9
    • 6
    • 6
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 282-415

    Specificity

    Occludin is a tetraspan integral membrane protein in epithelial and endothelial tight junction (TJ) structures that can contain two extracellular loops. The protein exists in a variety of phosphorylated forms. Phosphorylation is involved in regulating both the localization and the function of Occludin. Expression of Occludin is upregulated by polyunsaturated fatty acids, increasing trans-endothelial cell resistance and reducing cellular permeability to large molecules. The level of Occludin varies greatly depending on tissue, in brain tissue, Occludin is highly expressed at cell-cell contact sites. Non-neural tissues show lower expression and discontinuous distribution. Occludin is a tight junction protein that is a key structural component of the blood-brain barrier (BBB). Degradation of Occludin is frequently seen in ischemic stroke and contributes to BBB disruption.

    Cross-Reactivity (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant fragment of human Occludin protein (around aa 282-415) (exact sequence is proprietary)

    Isotype

    IgG1 kappa
  • Application Notes

    Known_Application: Western Blot (1-2 μg/mL),Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: HepG2 cells. Kidney.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Expiry Date

    24 months
  • Target

    Occludin (OCLN)

    Alternative Name

    OCLN

    Background

    BLCPMG, Occludin, OCLN, Phosphatase 1 regulatory subunit 115, PTORCH1, Tight junction protein occludin,Occludin (Marker of Early Blood Brain Barrier Damage)
    Cellular localisation: Cell Surface and Cytoplasmic

    Molecular Weight

    60-82kDa

    Gene ID

    100506658, 592605

    UniProt

    Q16625

    Pathways

    Cell-Cell Junction Organization, Hepatitis C
You are here:
Chat with us!